首页> 外文期刊>Mathematical research letters: MRL >Anticoagulant and antiplatelet combined therapy in patients 75 years and over with atrial fibrillation: a prospective observational study assessing adherence to clinical guidelines
【24h】

Anticoagulant and antiplatelet combined therapy in patients 75 years and over with atrial fibrillation: a prospective observational study assessing adherence to clinical guidelines

机译:患者的抗凝血剂和抗血小板组合治疗75岁及以上的心房颤动:评估临床指南依从性的前瞻性观察研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective According to current guidelines on atrial fibrillation (AF), the addition of an antiplatelet therapy to an anticoagulant for a stable vascular disease does not decrease the ischaemic hazard but increases the risk of bleeding. The aim of the study was to assess compliance of practices with existing clinical guidelines concerning the use of anticoagulant-antiplatelet combined therapy in patients 75 years and over with AF.
机译:目的根据目前的心房颤动指南(AF),向稳定血管疾病的抗凝血剂添加抗血小板治疗不会降低缺血性危害,但增加出血的风险。 该研究的目的是评估实践的遵守情况与现有临床指南有关使用抗凝血剂 - 抗血小板合并治疗的临床指南,患者75岁及以上。

著录项

  • 来源
  • 作者单位

    Univ Hosp Strasbourg Dept Pharm Strasbourg France;

    Univ Strasbourg Dept Pharm EA 7296 Fac Pharm Lab Neurocardiovasc Pharmacol &

    Toxicol Univ Hosp Strasbourg France;

    Univ Hosp Strasbourg Dept Pharm Strasbourg France;

    Univ Hosp Strasbourg Dept Geriatr Strasbourg France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 数学;
  • 关键词

  • 入库时间 2022-08-20 03:46:10

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号